| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |